ADMA Biologics, Inc. (ADMA)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about ADMA Biologics, Inc. (ADMA)
Go deeper and ask any question about ADMA
Company Performance
Current Price
as of Sep 13, 2024$18.09
P/E Ratio
128.66
Market Cap
$4.22B
Description
ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.
Metrics
Overview
- HQRamsey, NJ
- SectorHealth Technology
- IndustryBiotechnology
- TickerADMA
- Price$18.09+2.49%
Trading Information
- Market Cap$4.22B
- Float96.61%
- Average Daily Volume (1m)3,876,001
- Average Daily Volume (3m)3,826,680
- EPS$0.15
Company
- Revenue$330.24M
- Rev Growth (1yr)78.29%
- Net Income$32.06M
- Gross Margin53.47%
- EBITDA Margin38.48%
- EBITDA$41.25M
- EV$2.76B
- EV/Revenue8.36
- P/E128.66
- P/S13.27